ZC3H12C

ZC3H12C (MCPIP3/Regnase-3) is an endoribonuclease of the MCPIP/Regnase family that post-transcriptionally restrains inflammation and cell proliferation by directly cleaving target mRNAs through its NYN/PIN domain. It degrades pro-inflammatory transcripts including TNF, IL-6, IκBζ, and Regnase-1 mRNAs, and is itself reciprocally regulated by Regnase-1-mediated degradation of its own mRNA, forming a mutual post-transcriptional feedback loop (PMID:34215755, PMID:34298932). Beyond mRNA decay, ZC3H12C suppresses NF-κB and MAPK (JNK, ERK, p38) signaling in macrophages, modulates alternative splicing of STAT1 pre-mRNA, and regulates macrophage survival, migration, and phagocytosis, with conditional knockout leading to exacerbated kidney inflammation (PMID:33157351, PMID:38810592, PMID:40834429). In keratinocytes, ZC3H12C directly cleaves cyclin B1 mRNA at its 3′ UTR to control cell cycle progression and epidermal differentiation, and forms complexes with 14-3-3 proteins and keratin 14 that cooperatively regulate G2/M transition (PMID:40200325, PMID:41006702).

1. 2018 Medium

   The first functional characterization showed that ZC3H12C overexpression suppresses epithelial-mesenchymal transition markers and inhibits migration/invasion in colorectal cancer cells, establishing a potential anti-tumorigenic role independent of its later-defined RNase mechanism.

   Evidence Tet-on inducible overexpression in SW620/HCT116 cells with wound-healing and Transwell assays

   PMID:29751537

   Open questions at the time

   • Upstream mechanism and direct molecular targets not identified
   • No loss-of-function validation
   • Not tested in non-cancer cell contexts
2. 2020 Medium

   Epistasis experiments placed ZC3H12C as a negative regulator of NF-κB signaling in macrophages, downstream of the transcription factor Gfi1, revealing its role in an anti-inflammatory feedback circuit.

   Evidence Double KO of Gfi1 and Zc3h12c in macrophages with transcriptomic profiling and NF-κB pathway inactivation

   PMID:33157351

   Open questions at the time

   • Whether NF-κB suppression is direct (RNase-dependent) or indirect was not resolved
   • Single lab study
   • Mechanism of Gfi1-mediated Zc3h12c upregulation not defined
3. 2021 High

   The core enzymatic identity of ZC3H12C was established: its NYN/PIN domain directly degrades IL-6, TNF, Regnase-1, and IκBζ mRNAs, with substrate specificity distinct from other family members (e.g., unique TNF targeting, no IL-1β degradation), and a reciprocal Regnase-1–MCPIP3 mRNA degradation loop was discovered.

   Evidence In vitro RNase assays, reporter and mRNA stability assays, MCPIP3-deficient macrophages/pDCs, imiquimod in vivo model

   PMID:34215755 PMID:34298932 PMID:35048402

   Open questions at the time

   • Structural basis of substrate selectivity not determined
   • Stem-loop or cis-element requirements in target mRNAs not mapped
   • Relative contributions of RNase activity versus signaling suppression to anti-inflammatory phenotypes unclear
4. 2022 High

   In vivo genetic evidence confirmed that dendritic cell-intrinsic ZC3H12C restrains TNF-driven lymphadenopathy, linking its RNase activity to a physiological immune phenotype rescuable by Tnf deletion.

   Evidence DC-conditional KO mice (GFP knock-in), lymphadenopathy phenotyping, genetic epistasis via Tnf deletion rescue

   PMID:35048402

   Open questions at the time

   • Whether ZC3H12C acts on TNF mRNA cotranscriptionally or post-export not resolved
   • Redundancy with Regnase-1 in DCs not systematically tested
   • Upstream signals activating ZC3H12C in DCs undefined
5. 2024 Medium

   ZC3H12C was shown to suppress not only NF-κB but also JNK, ERK, and p38 MAPK pathways and TNF-α promoter activity in LPS-stimulated macrophages, broadening its anti-inflammatory mechanism beyond mRNA decay to signaling pathway inhibition.

   Evidence Overexpression/depletion in macrophages, luciferase reporter for TNF-α promoter, western blot for MAPK/NF-κB signaling

   PMID:38810592

   Open questions at the time

   • Whether MAPK suppression is a direct effect or secondary to mRNA degradation of upstream regulators not distinguished
   • Single lab with overexpression/depletion approach
   • No identification of direct protein-level interactions with MAPK components
6. 2025 Medium

   The functional scope of ZC3H12C was extended to two new contexts: in macrophages, it modulates STAT1 alternative splicing and regulates survival/migration/phagocytosis relevant to kidney injury; in keratinocytes, it directly cleaves cyclin B1 mRNA 3′ UTR and forms complexes with 14-3-3 and keratin 14 to control G2/M cell cycle progression and epidermal differentiation.

   Evidence Macrophage conditional KO (Tnfrsf11aCre) with scRNA-seq and in silico splicing analysis; keratinocyte-specific KO mice with reporter assays for nucleolytic cleavage; IP-MS and double thymidine block/release synchronization

   PMID:40200325 PMID:40834429 PMID:41006702

   Open questions at the time

   • Mechanism by which ZC3H12C, an RNase, modulates alternative splicing is unclear — direct versus indirect effects not resolved
   • Functional significance of individual 14-3-3 and keratin 14 interactions for RNase activity not tested
   • Whether cyclin B1 mRNA is a universal ZC3H12C target across cell types or keratinocyte-specific is unknown

• Key unresolved questions include the structural determinants of ZC3H12C substrate selectivity, the mechanism by which it modulates pre-mRNA splicing, whether its signaling-suppressive and RNase activities are mechanistically separable, and its full target mRNA repertoire across cell types.
• No crystal or cryo-EM structure available for ZC3H12C
• Genome-wide target identification (e.g., CLIP-seq) not performed
• Separation-of-function mutations distinguishing RNase from signaling roles not generated